// App-Quantinova.ai

AB0025 (2021) : CITRULLINATED-PEPTIDE SPECIFIC CD4+ T CELL RESPONSES IN RHEUMATOID ARHRITIS

Researchers

Presenter

  • J. Swift

Principal Investigators

  • J. Stanway

  • C. Hilkens

  • F. Stevenaert

  • A. Anderson

  • A. Pratt

  • J. D. Isaacs

Medical Centers

  • Newcastle University, Translational and Clinical Research Institute, Newcastle Upon Tyne, United Kingdom

  • Janssen Pharmaceutica, Immunosciences, Beerse, Belgium

Locations

  • United Kingdom

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Peripheral blood mononuclear cell

  • Cluster of Differentiation 4

  • Interleukin 17A

  • Interleukin-21

  • Interleukin 4

  • Interferon-gamma

Drug/Treatment

  • Brefeldin A

  • lonomycin

  • Recombinant Interleukin 21

  • Interferon Gamma

  • IFN-lambda

  • IL-4

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Pfizer

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved